Biotherapeutics and chronic diseases with relevance to insulin resistance and dementia

Research output: Contribution to conferenceAbstract

Abstract

Biotherapeutics and nutritional biotherapy have become important to reverse global chronic diseases such as non alcoholic fatty liver disease, diabetes and neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease that have become of major concern to the developed and developing world. Factors such as stress, core body temperature and food quality influence biotherapeutics with chronic and neurodegenerative diseases associated with dementia and dementia care. Biotherapeutics that involve Indian spice therapy require reassessment with relevance to the prevention of uncontrolled mitochondrial apoptosis. The identification of anti-aging genes are necessary for biotherapeutics and the understanding of transcriptional regulation of gene expression and maintenance of cell survival in the periphery and the brain. These anti-aging genes are linked to appetite, longevity and mitochondrial biogenesis with relevance to the dementia care in various global populations. The role of biotherapeutics such as magnesium therapy is associated with cell survival and reassessment of biotherapeutics with relevance to insulin resistance and programmed cell death is critical to dementia and dementia care.

Original languageEnglish
Publication statusPublished - 15 Apr 2019
Event2nd International Conference on Dementia and Dementia Care - Toronto, Canada
Duration: 17 Apr 201918 Apr 2019

Conference

Conference2nd International Conference on Dementia and Dementia Care
CountryCanada
CityToronto
Period17/04/1918/04/19

Fingerprint

Dementia
Insulin Resistance
Chronic Disease
Neurodegenerative Diseases
Cell Survival
Spices
Food Quality
Biological Therapy
Gene Expression Regulation
Organelle Biogenesis
Appetite
Body Temperature
Magnesium
Genes
Parkinson Disease
Alzheimer Disease
Cell Death
Maintenance
Apoptosis
Brain

Cite this

Martins, I. (2019). Biotherapeutics and chronic diseases with relevance to insulin resistance and dementia. Abstract from 2nd International Conference on Dementia and Dementia Care, Toronto, Canada.
Martins, Ian. / Biotherapeutics and chronic diseases with relevance to insulin resistance and dementia. Abstract from 2nd International Conference on Dementia and Dementia Care, Toronto, Canada.
@conference{7384ca20e0164abbaf80ad7b30a605ef,
title = "Biotherapeutics and chronic diseases with relevance to insulin resistance and dementia",
abstract = "Biotherapeutics and nutritional biotherapy have become important to reverse global chronic diseases such as non alcoholic fatty liver disease, diabetes and neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease that have become of major concern to the developed and developing world. Factors such as stress, core body temperature and food quality influence biotherapeutics with chronic and neurodegenerative diseases associated with dementia and dementia care. Biotherapeutics that involve Indian spice therapy require reassessment with relevance to the prevention of uncontrolled mitochondrial apoptosis. The identification of anti-aging genes are necessary for biotherapeutics and the understanding of transcriptional regulation of gene expression and maintenance of cell survival in the periphery and the brain. These anti-aging genes are linked to appetite, longevity and mitochondrial biogenesis with relevance to the dementia care in various global populations. The role of biotherapeutics such as magnesium therapy is associated with cell survival and reassessment of biotherapeutics with relevance to insulin resistance and programmed cell death is critical to dementia and dementia care.",
author = "Ian Martins",
year = "2019",
month = "4",
day = "15",
language = "English",
note = "2nd International Conference on Dementia and Dementia Care ; Conference date: 17-04-2019 Through 18-04-2019",

}

Martins, I 2019, 'Biotherapeutics and chronic diseases with relevance to insulin resistance and dementia' 2nd International Conference on Dementia and Dementia Care, Toronto, Canada, 17/04/19 - 18/04/19, .

Biotherapeutics and chronic diseases with relevance to insulin resistance and dementia. / Martins, Ian.

2019. Abstract from 2nd International Conference on Dementia and Dementia Care, Toronto, Canada.

Research output: Contribution to conferenceAbstract

TY - CONF

T1 - Biotherapeutics and chronic diseases with relevance to insulin resistance and dementia

AU - Martins, Ian

PY - 2019/4/15

Y1 - 2019/4/15

N2 - Biotherapeutics and nutritional biotherapy have become important to reverse global chronic diseases such as non alcoholic fatty liver disease, diabetes and neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease that have become of major concern to the developed and developing world. Factors such as stress, core body temperature and food quality influence biotherapeutics with chronic and neurodegenerative diseases associated with dementia and dementia care. Biotherapeutics that involve Indian spice therapy require reassessment with relevance to the prevention of uncontrolled mitochondrial apoptosis. The identification of anti-aging genes are necessary for biotherapeutics and the understanding of transcriptional regulation of gene expression and maintenance of cell survival in the periphery and the brain. These anti-aging genes are linked to appetite, longevity and mitochondrial biogenesis with relevance to the dementia care in various global populations. The role of biotherapeutics such as magnesium therapy is associated with cell survival and reassessment of biotherapeutics with relevance to insulin resistance and programmed cell death is critical to dementia and dementia care.

AB - Biotherapeutics and nutritional biotherapy have become important to reverse global chronic diseases such as non alcoholic fatty liver disease, diabetes and neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease that have become of major concern to the developed and developing world. Factors such as stress, core body temperature and food quality influence biotherapeutics with chronic and neurodegenerative diseases associated with dementia and dementia care. Biotherapeutics that involve Indian spice therapy require reassessment with relevance to the prevention of uncontrolled mitochondrial apoptosis. The identification of anti-aging genes are necessary for biotherapeutics and the understanding of transcriptional regulation of gene expression and maintenance of cell survival in the periphery and the brain. These anti-aging genes are linked to appetite, longevity and mitochondrial biogenesis with relevance to the dementia care in various global populations. The role of biotherapeutics such as magnesium therapy is associated with cell survival and reassessment of biotherapeutics with relevance to insulin resistance and programmed cell death is critical to dementia and dementia care.

M3 - Abstract

ER -

Martins I. Biotherapeutics and chronic diseases with relevance to insulin resistance and dementia. 2019. Abstract from 2nd International Conference on Dementia and Dementia Care, Toronto, Canada.